Jasper Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JSPR and other ETFs, options, and stocks.About JSPR
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation.
CEORonald A. Martell
CEORonald A. Martell
Employees25
Employees25
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2018
Founded2018
Employees25
Employees25
JSPR Key Statistics
Market cap23.17M
Market cap23.17M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume18.37K
Average volume18.37K
High today$0.63
High today$0.63
Low today$0.60
Low today$0.60
Open price$0.6137
Open price$0.6137
Volume10.52K
Volume10.52K
52 Week high$10.69
52 Week high$10.69
52 Week low$0.59
52 Week low$0.59
JSPR Earnings
-$0.69
-$0.46
-$0.23
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 17, Pre-Market
ActualExpected Mar 17, Pre-Market